Allison Dorval, Director at PUMA BIOTECHNOLOGY, INC. (PBYI), sold 11,610 shares at $7.20 ($84K) on 2026-06-12, disclosed to the SEC on 2026-06-15.
Scheduled sale ($84k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| VERV | SELL | 2024-12-03 | $3K | — | Filing → |
| PBYI | SELL | 2024-06-17 | $37K | — | Filing → |
| VERV | SELL | 2023-12-01 | $6K | — | Filing → |